872
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Validating the US pancreas donor risk index in a Norwegian population, a retrospective observational study

ORCID Icon, , , , , , , ORCID Icon & show all
Pages 345-351 | Received 03 Sep 2021, Accepted 24 Nov 2021, Published online: 07 Feb 2022

Figures & data

Figure 1. PRISMA flow diagram describing the inclusion and exclusion process of donor/recipient matches in a Norwegian population 2000–2019. All 13 were Danish recipients—included in the analyses, represented as censored cases in the Kaplan Meier survival analysis.

Figure 1. PRISMA flow diagram describing the inclusion and exclusion process of donor/recipient matches in a Norwegian population 2000–2019. All 13 were Danish recipients—included in the analyses, represented as censored cases in the Kaplan Meier survival analysis.

Table 1. Donor and recipient characteristics in a Norwegian cohort of pancreas transplantation 2000–2019.

Table 2. Comparison of the US and Norwegian cohort characteristics in donors and recipients of pancreas transplantations.

Table 3. Distribution of PDRI in a Norwegian cohort, compared to the US-based original.

Figure 2. Kaplan Meier 1-year survival by graft type. PTA: pancreas transplant alone; SPK: simultaneous pancreas kidney transplantation; PAK: pancreas after kidney transplantation.

Figure 2. Kaplan Meier 1-year survival by graft type. PTA: pancreas transplant alone; SPK: simultaneous pancreas kidney transplantation; PAK: pancreas after kidney transplantation.

Figure 3. Kaplan Meier 1-year survival curves by graft type and PDRI quintile. PTA: pancreas transplant alone; SPK: simultaneous pancreas kidney transplantation; PAK: pancreas after kidney transplantation.

Figure 3. Kaplan Meier 1-year survival curves by graft type and PDRI quintile. PTA: pancreas transplant alone; SPK: simultaneous pancreas kidney transplantation; PAK: pancreas after kidney transplantation.

Table 4. 1-year pancreas graft survival in a Norwegian population, by PDRI and transplant type.

Data availability statement

The datasets generated and analysed during the current study are not publicly available due to Norwegian national legislation prohibiting the publishing of information that could compromise research participant privacy. The collected data are of such nature that it falls under the provisions of the Norwegian Health Research Act. The data are available from Oslo University hospital’s data protection official for research upon reasonable request, contact via [email protected], for researchers who meet the criteria for access to confidential data.